Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Buy 7 month bank deposit or 7 months of AVXL stock..With 3 trials starting in the CNS space with safe profiles, I choose AVXL eventhough the bank cd can return me .03% !
ASCO first week of June, imo this may see $25+ in June.
Only publicly traded Bitcoin miner, $8+ imo.
MGT Capital Announces Major Expansion of Bitcoin Mining (MGTI)
There is one traded....MGTI
Bitcoin Miner run by John Mcafee is MGTI. Read the pr. increasing production. Speculative.
GLYC and AVXL are the biggest biotech winners in the next 6 months imo.
Did anyone read this? In the transcript of the quarterly meeting, LITE says they have received an initial order of multi million units for their 3D sensor. See the transcript under Seeking Alpha for LITE. Is it the iphone or other smart phone? From zero to multi million, something big is up imo.
Major medical breakthrough in AML. See you at $60+ Grabbing any shares under $15.
3 month range bound due to major accumulation before major breakout. Shorts turning long for a much bigger move up (unlimited) compared to only a possible $5 drop. They know well how to manipulate to get the position they want before the big move up.
AmazonPharma expamding internationally. Australian operations going worldwide. Imo aquiring AVXL for Alzheimers would be huge since successful trials were run in Australia.
Will AVXL be the first AmazonPharma acquisition? CNBC reports Amazon expanding into pharma internationally and AmazonPharma big in Australia already.
Hasn't anyone read the transcripts from earnings? and the Q and A session? Multi million unit order for September quarter and thats just the initial order !
BABA and BZUN, the Netflix and Amazon of China !
BZUN, SINA, WB, BABA, BIDU all going higher. BZUN market cap is best value among others and should grow the fastest. Amazing earnings.
Zika Season !
Institutional Ownership rises again. Accumulation and grabbing shares at investors stop loss prices is normal for them to own more !
Institutional holdings increasing again, now 24.16%. Institutions now own one-fourth of AVXL!
AD trials will be in US, UK and Australia !
Do your own DD. Some do more than others.
They are awaiting the PK data to finalize design of all 3 trials. I would double up as soon as I see the PK release, if they release one.
NVDA and MZOR Wednesday big winners !
Extremely undervalue market cap. Could open one morning at $20+ and still be undervalued compared to peers.
Super undervalued. Could open at $50+
BIIB down again, Certainly needs an addition to their pipeline !
Alan Lowe
Sure. Well, we're at very low levels this quarter. The orders that we received for the September quarter are multi-million units. We expect that to continue to grow. And we're bringing on capacity at our partners this quarter, and into early next quarter that we believe should suffice -- be able to meet the initial ramp, and then we'll revaluate as we make progress with other of our customers. I think our partners and we have invested sufficiently for the existing ramp, and are brining capacity online as fast as we possibly can to meet the ramp.
PATENT:
This invention concerns a dosage form comprising a therapeutically neuroprotective amount of A2-73 and a neuroprotective amount of at least one cooperating acetylcholinesterase inhibitor selected from the group consisting of donepezil, galantamine, rivastigmine, or memantine and method of use.
Where is link for patent on AV plus?
$5 tomorrow?
MTBCP is their previous preferred, if needed they will issue more preferred rather than dilute with stock. This health care company benefits from changes in health reporting and now add in the vast amount of hospitals from recent Pr. As I said before this is starting to hit on major cylinders. Charts show an all time highh can be reached.
This company is hitting on all cylinders and won't issue more stock because they issue non dilutive preferreds. Ebitda positive in 2017 accordfing to pr release.
TRPX using FDA approved Dronabinol (synthetic THC) in Tourettes and other CNS diseases. Micro cap. Yale University. 505-b-2. Should catch MC values of ZYNE and GWPH imo.
Let's do some math:
22,000 Rhetts patients in the U.S. Let's be conservative and say AVXL treats only 15,000 and costs 200,000 dollars each. That is a 3 Billion dollar drug ! Imo those are conservative figures.
I am looking for AD trials to be held in 3 places, The U.S, Australia and Europe.
Gave you ZYNE a year ago at $7, now giving you TRPX. They are using FDA approved Dromabinol ( synthetic THC ) and unique delivery systems for Torettes and CNS diseases via 505-b-2. New and unknown and 3.7 million outstanding with no cash needs.
Jefferies initiates with a buy rating and a $23 PT.
Imo, AD trials will probably be held in Europe, the U.S. and also Australia soon after PK data is received to finalize trial design for optimal success.
Fundamentals and charts show a move to at least $13+
Low market Cap can easily go to $65. Even Cramer says its a young ISRG.
Why did it not pass? These are the votes. More yes than No.
Proposal No. 2: Regarding a vote to amend the Company’s Articles of Incorporation to authorize up to 10,000,000 shares of preferred stock of the Company, par value $0.001 per share. The stockholders did not submit enough affirmative votes to approve the amendment of the Company’s Articles of Incorporation as set forth in this proposal with respect to authorizing 10,000,000 shares of preferred stock of the Company as follows:
Votes For 18,659,912
Votes Against 2,218,830
Abstentions 258,932
Broker Non-Votes 11,605,706
Opens the door to a Hostile Bid soon imo. Institutions would take $25-$30.
Business looks like it's taking this to $1.